Incretin Mimetics and Dipeptidyl Peptidase-IV Inhibitors: A Review of Emerging Therapies for Type 2 Diabetes
Author:
Affiliation:
1. Amylin Pharmaceuticals, Inc., San Diego, California.
Publisher
Mary Ann Liebert Inc
Subject
Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism
Link
http://www.liebertpub.com/doi/pdf/10.1089/dia.2006.8.385
Reference81 articles.
1. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
2. The pathophysiological basis for intensive insulin replacement
3. Abstracts of the IDF Congress in Paris 2003
4. Pharmacologic Therapy for Type 2 Diabetes Mellitus
5. Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance®) in type 2 diabetes
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Metabolic syndrome and neuroprotection;SCT Proceedings in Interdisciplinary Insights and Innovations;2024-06-12
2. Replacement of the C-terminal Trp-cage of exendin-4 with a fatty acid improves therapeutic utility;Biochemical Pharmacology;2018-05
3. Metabolic Syndrome and Neuroprotection;Frontiers in Neuroscience;2018-04-20
4. A Computational Method to Determine Glucose Infusion Rates for Isoglycemic Intravenous Glucose Infusion Study;IEEE Journal of Biomedical and Health Informatics;2016-01
5. Non-insulin hypoglycemic drugs;Meyler's Side Effects of Drugs;2016
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3